Skip to main content
. 2006 Mar 6;148(2):137–146. doi: 10.1038/sj.bjp.0706714

Table 1.

Left ventricular structure in HF-rabbits after 1, 2 and 3 weeks of rapid left ventricular pacing and HF-rabbits after 3 weeks of rapid left ventricular pacing, treated for 2 or 3 weeks with sabiporide, and Shams, treated for 3 weeks with sabiporide

Groups
CM Apoptosis
CM hypertrophy (CSA, μm2)
Myocardial fibrosis (% of area)
  TUNEL-positive CM Area (mm2) TUNEL-positive CM (mm−2 × 10−3)    
Progression of heart failure
Shams (n=9)
0.6±0.2
116±7
5±2
251±15
7±1
1wkHF (n=6)
1.8±0.8
127±18
16±6
282±12
8±1
2wksHF (n=7)
2.1±0.3
118±11
18±3
295±12
13±1
3wksHF (n=8)
7.5±1.6*
139±18
50±10*
317±17*
19±2*
 
Sabiporide treatment
Shams+3wksSABI (n=7)
1.4±0.5
175±5
9±3
227±11
5±1
3wksHF+2wksSABI (n=7)
2.6±1.1
117±9
21±9*,#
257±13#
16±1*,#
3wksHF+3wksSABI (n=9) 5.8±1.3* 169±16 35±6*,# 294±9*,# 12±1#

Area=total analyzed surface area; CM=cardiomyocyte; CSA=cross-sectional area; HF=heart failure; SABI=sabiporide.

Values are Means±s.e.m. with *P<0.05 vs Shams and #P<0.05 vs 3wksHF.